#United States #New York #Class Action #Pomerantz #Ardelyx

Pomerantz Law Firm Warns Ardelyx, Inc. Investors

On November 5, 2026, Pomerantz LLP informed investors about a class action lawsuit filed against Ardelyx, Inc. This legal action has significant implications for those who experienced losses, urging them to seek potential recovery. The lawsuit focuses on allegations of securities fraud and other unlawful business practices by Ardelyx and some of its management.

Background of the Case

The need for this class action became evident following Ardelyx's announcement on August 6, 2026, when the company reduced its revenue guidance significantly for its IBSRELA treatment and withdrew its revenue forecasts for XPHOZAH due to evolving market conditions. According to management, the lowered guidance for IBSRELA was primarily due to increased utilization-management processes imposed by payers, which hinders patient access and slows the initiation of treatments for new patients. These developments significantly affected the stock's market performance, leading to a notable drop in Ardelyx's share price by 17.86%, closing at $4.00 on August 7, 2026.

Legal Assistance for Affected Investors

Investors who purchased Ardelyx securities during the specified class period and suffered losses are advised to reach out to Pomerantz LLP. Interested individuals can contact Danielle Peyton via email at [email protected] or by calling 646-581-9980, or toll-free at 888-4-POMLAW, Ext. 7980. For those reaching out via email, it's recommended to include personal contact details, including a mailing address, phone number, and the number of shares acquired.

It is critical for investors to act promptly, as they have until November 16, 2026, to petition the court to appoint them as Lead Plaintiff in this case. This opportunity is paramount for securing their voice in the legal proceedings and potentially gaining from any recovery processes.

The Firm's Reputation

Pomerantz LLP is recognized as a leading law firm specializing in corporate, securities, and antitrust class litigation. With a legacy dating back over 85 years, the firm was founded by Abraham L. Pomerantz, who is revered as a pioneer in the field of securities class actions. Throughout its history, Pomerantz has recovered substantial damages on behalf of class members, reflecting its commitment to fighting for the rights of those affected by securities fraud and corporate malfeasance.

Conclusion

As the case unfolds, affected investors should stay informed about the proceedings and consider their options regarding participation. Ardelyx, Inc.'s recent market struggles serve as a reminder of the unpredictability of investment landscapes and the importance of legal protections available for investors. For further information on joining the class action, please visit Pomerantz Law Firm's website.

This is an attorney advertisement and prior results do not guarantee similar outcomes.